Steven St. Peter
Managing Director at JDRF T1D Fund
Steven St. Peter
Managing Director at JDRF T1D Fund
Boston, Massachusetts
Overview
Work Experience
Founder and Managing Director
2012 - Current
Managing Director
2019
The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund accelerating life-changing solutions to cure, prevent, and treat type1 diabetes (T1D) through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, corporations and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, diagnostics, and devices into the hands of those living with T1D. The T1D Fund invests in areas strategically aligned with JDRF, the leading global organization funding T1D research.
Chairman Of The Supervisory Board
2019 - 2020
iOmx Therapeutics AG focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoints hijacked by cancer cells. iOmx is building a pipeline of promising cancer immunotherapeutics based on novel, proprietary targets with a known mode of action. Founded in 2016 based on the work conducted at the German Cancer Research Center, the company has been funded by MPM Capital , Sofinnova Partners, Wellington Partners and Merck Ventures and is based in Martinsried / Munich, Germany.
President & CEO
2012 - 2019
Managing Director
2004 - 2012
Sourced, led, and managed investments.
Principal
2001 - 2003
Venture Capital
Senior Associate
1999 - 2001
Analyst
1989 - 1991